BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26553031)

  • 1. Prediction of critical weight loss during radiation treatment in head and neck cancer patients is dependent on BMI.
    Lønbro S; Petersen GB; Andersen JR; Johansen J
    Support Care Cancer; 2016 May; 24(5):2101-2109. PubMed ID: 26553031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Body Composition With Survival and Locoregional Control of Radiotherapy-Treated Head and Neck Squamous Cell Carcinoma.
    Grossberg AJ; Chamchod S; Fuller CD; Mohamed AS; Heukelom J; Eichelberger H; Kantor ME; Hutcheson KA; Gunn GB; Garden AS; Frank S; Phan J; Beadle B; Skinner HD; Morrison WH; Rosenthal DI
    JAMA Oncol; 2016 Jun; 2(6):782-9. PubMed ID: 26891703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of nutrition support on treatment outcome in patients with locally advanced head and neck squamous cell cancer treated with definitive radiotherapy: a secondary analysis of RTOG trial 90-03.
    Rabinovitch R; Grant B; Berkey BA; Raben D; Ang KK; Fu KK; Cooper JS;
    Head Neck; 2006 Apr; 28(4):287-96. PubMed ID: 16287132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An exploration of factors predicting malnutrition in patients with advanced head and neck cancer.
    Silander E; Nyman J; Hammerlid E
    Laryngoscope; 2013 Oct; 123(10):2428-34. PubMed ID: 23918730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weight loss and body mass index in relation to aspiration in patients treated for head and neck cancer: a long-term follow-up.
    Ottosson S; Lindblom U; Wahlberg P; Nilsson P; Kjellén E; Zackrisson B; Levring Jäghagen E; Laurell G
    Support Care Cancer; 2014 Sep; 22(9):2361-9. PubMed ID: 24687537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of obesity on the survival of patients with early-stage squamous cell carcinoma of the oral tongue.
    Iyengar NM; Kochhar A; Morris PG; Morris LG; Zhou XK; Ghossein RA; Pino A; Fury MG; Pfister DG; Patel SG; Boyle JO; Hudis CA; Dannenberg AJ
    Cancer; 2014 Apr; 120(7):983-91. PubMed ID: 24449483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enteral feeding during chemoradiotherapy for advanced head-and-neck cancer: a single-institution experience using a reactive approach.
    Clavel S; Fortin B; Després P; Donath D; Soulières D; Khaouam N; Charpentier D; Bélair M; Guertin L; Nguyen-Tan PF
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):763-9. PubMed ID: 20510546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of a predictive score for malnutrition in patients treated by irradiation for head and neck cancer: a retrospective study in 127 patients].
    Lescut N; Personeni E; Desmarets M; Puyraveau M; Hamlaoui R; Servagi-Vernat S; Bosset JF; Nguyen F
    Cancer Radiother; 2013 Nov; 17(7):649-55. PubMed ID: 24183935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of weight loss during and after radiotherapy in patients with head and neck cancer: A longitudinal study.
    Lee SC; Wang TJ; Chu PY
    Eur J Oncol Nurs; 2019 Apr; 39():98-104. PubMed ID: 30850144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age most significant predictor of requiring enteral feeding in head-and-neck cancer patients.
    Sachdev S; Refaat T; Bacchus ID; Sathiaseelan V; Mittal BB
    Radiat Oncol; 2015 Apr; 10():93. PubMed ID: 25896830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular risk and prevention in patients with head and neck cancer treated with radiotherapy.
    Okoye CC; Bucher J; Tatsuoka C; Parikh SA; Oliveira GH; Gibson MK; Machtay M; Yao M; Zender CA; Dorth JA
    Head Neck; 2017 Mar; 39(3):527-532. PubMed ID: 28032680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with weight loss during radiotherapy in patients with stage I or II head and neck cancer.
    Nourissat A; Bairati I; Fortin A; Gélinas M; Nabid A; Brochet F; Têtu B; Meyer F
    Support Care Cancer; 2012 Mar; 20(3):591-9. PubMed ID: 21424341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of obesity on outcomes for patients with head and neck cancer.
    Hicks DF; Bakst R; Doucette J; Kann BH; Miles B; Genden E; Misiukiewicz K; Posner M; Gupta V
    Oral Oncol; 2018 Aug; 83():11-17. PubMed ID: 30098765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-therapeutic fibrinogen levels are of prognostic significance in locally advanced head and neck cancer.
    Selzer E; Grah A; Heiduschka G; Kornek G; Thurnher D
    Wien Klin Wochenschr; 2016 May; 128(9-10):320-8. PubMed ID: 26919854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the role of prophylactic gastrostomy tube placement prior to definitive chemoradiotherapy for head and neck cancer.
    Chen AM; Li BQ; Lau DH; Farwell DG; Luu Q; Stuart K; Newman K; Purdy JA; Vijayakumar S
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1026-32. PubMed ID: 20231073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nutrition outcomes following implementation of validated swallowing and nutrition guidelines for patients with head and neck cancer.
    Brown T; Ross L; Jones L; Hughes B; Banks M
    Support Care Cancer; 2014 Sep; 22(9):2381-91. PubMed ID: 24691885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive resistance training rebuilds lean body mass in head and neck cancer patients after radiotherapy--results from the randomized DAHANCA 25B trial.
    Lønbro S; Dalgas U; Primdahl H; Johansen J; Nielsen JL; Aagaard P; Hermann AP; Overgaard J; Overgaard K
    Radiother Oncol; 2013 Aug; 108(2):314-9. PubMed ID: 23932192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of pretreatment body mass index on patients with head-and-neck cancer treated with radiation.
    Pai PC; Chuang CC; Tseng CK; Tsang NM; Chang KP; Yen TC; Liao CT; Hong JH; Chang JT
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e93-e100. PubMed ID: 22342298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eliminating radiotherapy to the contralateral retropharyngeal and high level II lymph nodes in head and neck squamous cell carcinoma is safe and improves quality of life.
    Spencer CR; Gay HA; Haughey BH; Nussenbaum B; Adkins DR; Wildes TM; DeWees TA; Lewis JS; Thorstad WL
    Cancer; 2014 Dec; 120(24):3994-4002. PubMed ID: 25143048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Locally advanced head and neck cancer treated with accelerated radiotherapy, the hypoxic modifier nimorazole and weekly cisplatin. Results from the DAHANCA 18 phase II study.
    Bentzen J; Toustrup K; Eriksen JG; Primdahl H; Andersen LJ; Overgaard J
    Acta Oncol; 2015 Jul; 54(7):1001-7. PubMed ID: 25629651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.